Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction [Corrigendum]
Ramphul M, Lo DKH, Gaillard EA. J Asthma Allergy. 2021;14:525–538. The authors have advised that Figures 1 and 2 on pages 528 and 533, respectively are in the reverse order. In the original article, Figure 1 appears as Figure 2, and Figure 2 as Figure 1. The Figures with the correct captio...
Main Authors: | Ramphul M, Lo DKH, Gaillard EA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-precision-medicine-for-paediatric-severe-asthma-current-st-peer-reviewed-fulltext-article-JAA |
Similar Items
-
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction
by: Ramphul M, et al.
Published: (2021-05-01) -
Evidence-Based Approach of Biologic Therapy in Bronchial Asthma
by: Adnan Liaqat, et al.
Published: (2023-06-01) -
Elaborate biologic approval process delays care of patients with moderate-to-severe asthma
by: Esha Sehanobish, PhD, et al.
Published: (2023-05-01) -
Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study
by: Koya T, et al.
Published: (2023-06-01) -
Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
by: Erminia Ridolo, et al.
Published: (2020-10-01)